AbbVie
Pharmaceuticals
ABBV
$ 155 (0.44)%
Share price
$ 274 bn
Market Cap
$ 328 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
AbbVie aims to reduce Scope 1 + 2 by 50% by 2035 from a base year 2015
This target has not been verified as science based according to SBTi
GHG emissions and Carbon intensity
AbbVie reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 508 Kt (-57 /-10.1% y-o-y). Also positively, carbon intensity fell to 11 t (-5.9 /-34.7% y-o-y).
No public disclosure of Scope 3 emissions has been found for AbbVie at the moment.
The company is committed to reducing Scope 1 + 2 by 50% by 2035 from a base year 2015, which translates into the estimated reduction of -12 Kt per annum over the period of FY2021 - FY2035. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Copyright © 2022 Exerica. All rights reserved.